Gene: SLC6A3 ×
Source: CURATED ×
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 6531
Gene Symbol: SLC6A3
SLC6A3 		0.300 Biomarker group CTD_human Lack of cocaine self-administration in mice expressing a cocaine-insensitive dopamine transporter. 19602552 2009
Entrez Id: 6531
Gene Symbol: SLC6A3
SLC6A3 		0.300 Therapeutic group CTD_human Lack of cocaine self-administration in mice expressing a cocaine-insensitive dopamine transporter. 19602552 2009
Entrez Id: 6531
Gene Symbol: SLC6A3
SLC6A3 		0.300 Biomarker group CTD_human A dopamine transporter gene functional variant associated with cocaine abuse in a Brazilian sample. 16537431 2006
Entrez Id: 6531
Gene Symbol: SLC6A3
SLC6A3 		0.300 Therapeutic group CTD_human A dopamine transporter gene functional variant associated with cocaine abuse in a Brazilian sample. 16537431 2006
Entrez Id: 6531
Gene Symbol: SLC6A3
SLC6A3 		0.300 Biomarker group CTD_human Self-administration of cocaine and the cocaine analog RTI-113: relationship to dopamine transporter occupancy determined by PET neuroimaging in rhesus monkeys. 11746736 2002
Entrez Id: 6531
Gene Symbol: SLC6A3
SLC6A3 		0.300 Therapeutic group CTD_human Self-administration of cocaine and the cocaine analog RTI-113: relationship to dopamine transporter occupancy determined by PET neuroimaging in rhesus monkeys. 11746736 2002
Entrez Id: 6531
Gene Symbol: SLC6A3
SLC6A3 		0.300 Therapeutic group CTD_human Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference. 11320258 2001
Entrez Id: 6531
Gene Symbol: SLC6A3
SLC6A3 		0.300 Biomarker group CTD_human Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference. 11320258 2001